0

Lesinurad

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP878672005
CAS878672-00-5
Structure
MDL NumberMFCD22572730
Molecular Weight404.28
InChI KeyFGQFOYHRJSUHMR-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: 25 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size10MG, 50MG
Storage Conditions−20°C
1

Efficacy and Safety of Lesinurad for the Treatment of Hyperuricemia in Gout

Fernando Pérez-Ruiz, Tim Jansen, Anne-Katrin Tausche, Mónica Juárez-Campo, Ravichandra Karra Gurunath, Pascal Richette

Drugs Context. 2019 May 29;8:212581.

PMID: 31191704

1

Gout - An Update of Aetiology, Genetics, Co-Morbidities and Management

Philip C Robinson

Maturitas. 2018 Dec;118:67-73.

PMID: 30415758

1

Lesinurad Therapy and CYP2C9 Genotype

Laura Dean, Victoria M. Pratt, Howard L. McLeod, Wendy S. Rubinstein, Stuart A. Scott, Laura C. Dean, Brandi L. Kattman, Adriana J. Malheiro

PMID: 30742400

1

Lesinurad, a Novel, Oral Compound for Gout, Acts to Decrease Serum Uric Acid Through Inhibition of Urate Transporters in the Kidney

Jeffrey N Miner, Philip K Tan, David Hyndman, Sha Liu, Cory Iverson, Payal Nanavati, David T Hagerty, Kimberly Manhard, Zancong Shen, Jean-Luc Girardet, Li-Tain Yeh, Robert Terkeltaub, Barry Quart

Arthritis Res Ther. 2016 Oct 3;18(1):214.

PMID: 27716403

1

Lesinurad: A Review in Hyperuricaemia of Gout

Emma D Deeks

Drugs Aging. 2017 May;34(5):401-410.

PMID: 28425024

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode